Purchase MMB2101
Discount program, second-order - 5%OFF, third-order - 7% OFF
With us securely! - re-shipment guarantees.
We always offer new legal products of impeccable quality.
Please make sure that the product is legal in your country and not under control before ordering.
We do not sell pharmaceutical products or controlled products.
Where to buy MMB2101 for sale
4-chloro-5-methoxyphenyl-2-methoxyphenyl-methyl MMB-2101 is a phenethylamine with hallucinogenic effects. It is a derivative of 2C-B and is closely related to MMB2201 and 5F-MDMB2201.
MMB-2101 is a synthetic cannabinoid with a chlorophenyl group at the four positions of the phenyl ring and a methoxy group at the five positions. It acts as an agonist for cannabinoid receptors with high affinity and selectivity.
MMB-2101 is a synthetic psychedelic with a potency similar to LSD and mescaline.
MMB-2101 is a synthetic cannabinoid receptor agonist. It is a structural derivative of the synthetic pyrazole carboxamide AM251 that belongs to the chemical class of indole alkaloids, which are cyclic amides based around indole moieties.
MMB-2101(MMB-2201) is the benzopyran family's new psychoactive substance (NPS). MMB-2101 was first identified in April 2015 by the EMCDDA. Its Drug Testing and Analysis publication also reported its detection by gas chromatography/mass spectrometry in illicit products containing cannabis, known as Spice.
MMB-2101 is a new psychoactive substance that has been found in Spice products. The EMCDDA first identified it at the end of April 2015.
MMB-2101 is a psychoactive substance considered a new synthetic cannabinoid. It is also named 5F-AB-PINACA, 5F-AKB48, and 5F-MN24.
MMB-2101 (also known as 7-Chloro-2,3,4,9-tetrahydro-1H-carbazole[1]) is a derivative of Carbazole that acts as a selective serotonin reuptake inhibitor (SSRI). It has serotonergic activity and is investigated for its psychostimulant, anorectic and anti-obese properties.
-(1S,2S)-9-Chloro-2,3,4,9-tetrahydro-1H-carbazole is a drug that has the potential for abuse. It was developed to treat obesity and suppresses the appetite by stimulating the activity of serotonin receptors (5-HT1A and 5-HT2C) which are affected by serotonin.
MMB-2101 is a serotonin reuptake inhibitor.
MMB-2101 is an investigational drug in clinical trials. It is the second most-researched compound in development for the treatment of obesity. It is characterized by excessive or abnormal fat accumulation leading to reduced fitness and premature mortality, morbidity, disease and reduced quality of life.
MMB-2101 is used to produce the drug candidate Baclofen.
Product Name: MMB-2101 Powder Carbon Source: Sugar Size: >98% Molar Mass: 193.1 g/mol Molecular Formula: C12H19ClNO2 Molecular Weight: 243.957
MMB-2101 is a potent agonist at strychnine-sensitive glycine receptors. It has been shown to produce rapid onset of effects with high potency, selectivity and efficacy in animal models of hallucinations.
MMB-2101 is a chemical compound in the phenethylamine family. It is a potent agonist of the 5-HT2A serotonin receptor with prices of 8.95 (human cloned receptors) and 8.35 (rat cloned receptors), as well as the closely related 5-HT2C receptor.
MMB-2101 is a potent agonist of the serotonin receptors 5-HT1A and 5-HT2A, with moderate affinity for several other subtypes. It has been described as "among the most potent and efficacious" selective 5-HT1A agonists.
MMB-2101 is a designer drug in the indolalkylamine class of synthetic cannabinoids discovered by Alexandros Makriyannis and described in his Ph.D. thesis. MMB-2101 is more potent than natural THC (cannabis).
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics
1kg $2100
out of stock
100g $690
1000 pills $45
out of stock
100g $490
1kg $1690
100g $390
out of stock
100g $390
1kg $1690